| Application no. and date | 13721433.4 (espacenet) (Federated) (European Patent Register), 20130410 | | Patent/reg. no. and date | DK/EP 2836595, 20170614 | | Publication date | 20150218 | | Priority no. and date | US 201261622288 P, 20120410, US 201313835613, 20130315 | | EP pub. no. and date |
EP 2836595 20150218 | | Effective date | | | Applicant/owner | Alnylam Pharmaceuticals, Inc., 300 Third Street
Cambridge, MA 02142, US,
Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place
New York, NY 10029, US | | Applicant ref. no. | Alnylam ALN-171EP_PO#4590002528 | | Inventor | DESNICK, Robert, J., 170 East 93rd Street
New York, NY 10128, US,
QUERBES, William, Alnylam Pharmaceuticals Inc.
300 Third Street
Cambridge, MA 02142, US,
BETTENCOURT, Brian, 300 Third Street
Cambridge, MA 02142, US,
FITZGERALD, Kevin, 40 Williams Street
Apt. 202
Brookline, MA 02446, US,
YASUDA, Makiko, 100 Overlook Terrace
Apartment 612
New York, NY 10040, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/713 (2006.01) , A61P 43/00 (2006.01) , C12N 15/113 (2010.01) | | Title | SAMMENSÆTNINGER OG FREMGANGSMÅDER TIL HÆMNING AF EKSPRESSION AF ALAS1-GENET | | Int. application no. | US2013036006 | | Int. publication no. | WO2013155204 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
